Based on news reporting.
Gossamer Bio, Inc. has laid off approximately 50 employees, which constitutes half of its workforce, following disappointing results from a clinical trial that led to a significant drop in stock prices. The layoffs are part of a restructuring effort aimed at reducing costs and refocusing the company's strategic priorities. This decision comes in the wake of challenges faced in the biotech sector, particularly concerning the efficacy of their drug candidates. The company is now looking to streamline operations and improve its financial standing after the trial setbacks.
Gossamer Bio, Inc. cut 50 jobs as of October 1, 2023.
LayoffTalk has tracked 2 layoff events at Gossamer Bio, Inc. since October 2023, affecting a combined 115 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
Gossamer Bio, Inc. cut 50 jobs on October 1, 2023. If you were part of this round, what was your experience? Others going through it are reading. You can post anonymously below.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.